RxSight, Inc.
For the period ended Apr 25, 2024. Filed Apr 25, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 25, 2024 · Filed Apr 25, 2024
Contents
PAY VERSUS PERFORMANCE
The following table sets forth the compensation for Ron Kurtz, M.D., our principal executive officer (“PEO”), and the average compensation for our named executive officers other than our PEO (“non-PEO NEOs”) for fiscal years 2023 and 2022 (each a “Covered Year”), both as reported in the Summary Compensation Table and with certain adjustments to reflect the “compensation actually paid” to such individuals, as calculated in accordance with rules adopted by the SEC in August 2022. “Compensation actually paid” does not reflect amounts actually realized by our PEO and Non-PEO NEOs and may be higher or lower than amounts, if any, that are actually realized by such individuals. The table below also provides information for each Covered Year regarding our cumulative total shareholder return and our net income.
| Value of Initial Fixed $100 Investment Based on: | ||||||
|---|---|---|---|---|---|---|
| Year | Summary Compensation Table Total for PEO ($)(1) | Compensation Actually Paid to PEO ($)(1)(2)(3) | Average Summary Compensation Table Total for Non-PEO NEOs ($)(1) | Average Compensation Actually Paid to Non-PEO NEOs ($)(1)(2)(3) | Total Shareholder Return ($)(4) | Net Income ($)(5) |
| 2023 | 3,081,597 | 11,796,221 | 1,808,267 | 6,263,724 | 358.40 | (48.6) |
| 2022 | 1,025,471 | 1,245,648 | 649,355 | 762,518 | 112.62 | (66.8) |
(1)
Ron Kurtz, M.D. was our PEO for each year presented. The individuals comprising the Non-PEO NEOs for each year presented are listed below.
2022-2023
Shelley Thunen
Eric Weinberg
Ilya Goldshleger, Ph.D.
(2)
The amounts shown for compensation actually paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
(3)
Compensation actually paid reflects the following exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718.
(4)
Total shareholder return represents the value (as of the last day of the Covered Year) of a $100 investment made at the close of trading on December 31, 2021, assuming reinvestment of dividends.
(5)
The dollar amounts reported are the Company's net income reflected in the Company’s audited financial statements.
| Fiscal Year | 2023 | 2022 |
|---|---|---|
| Summary Compensation Table Total for PEO ($) | 3,081,597 | 1,025,471 |
| Minus Grant Date Fair Value of Equity Awards in Summary Compensation Table ($) | (1,873,660) | — |
| Plus Year End Fair Value of Equity Awards Granted During Year That are Outstanding and Unvested at Fiscal Year End ($) | 5,196,271 | — |
| Plus Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($) | 3,697,445 | 130,781 |
| Plus Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($) | 709,996 | — |
| Plus Change in Fair Value between the Vesting Date and the End of the Prior Year of Equity Awards Granted in Prior Years that Vested in the Year ($) | 984,572 | 89,396 |
| Minus Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($) | — | — |
| Compensation Actually Paid to PEO ($) | 11,796,221 | 1,245,648 |
| Fiscal Year | 2023 | 2022 |
|---|---|---|
| Average Summary Compensation Table Total for Non-PEO NEOs ($) | 1,808,267 | 649,355 |
| Minus Non-PEO NEO Average Grant Date Fair Value of Equity Awards in Summary Compensation Table ($) | (1,046,127) | — |
| Plus Non-PEO NEO Average Year End Fair Value of Equity Awards Granted During Year That are Outstanding and Unvested at Fiscal Year End ($) | 2,900,854 | — |
| Plus Non-PEO NEO Average Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($) | 1,649,593 | 60,319 |
| Plus Non-PEO NEO Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($) | 396,411 | — |
| Plus Non-PEO NEO Average Year over Year Change in Fair Value between the Vesting Date and the End of the Prior Year of Equity Awards Granted in Prior Years that Vested in the Year ($) | 554,726 | 52,844 |
| Minus Non-PEO NEO Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($) | — | — |
| Average Compensation Actually Paid to Non-PEO NEOs ($) | 6,263,724 | 762,518 |
Relationship Descriptions
Description of Relationship Between PEO and Non-PEO NEO Compensation actually paid and company Total Shareholder Return (“TSR”)
The following chart sets forth the relationship between compensation actually paid to our PEO, the average of compensation actually paid to our Non-PEO NEOs, and the Company’s cumulative TSR over the two most recently completed fiscal years.
Description of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Income
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, and our Net Income during the two most recently completed fiscal years.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.